Sex-Specific Total Testosterone and Dehydroepiandrosterone Sulfate Status in Noncritically Ill Hospitalized Patients with Coronavirus Disease 2019: A Cross-Sectional Study.
Androgen
Coronavirus Disease 2019
Noncritical
Testosterone
dehydroepiandrosterone Sulfate
Journal
International journal of fertility & sterility
ISSN: 2008-076X
Titre abrégé: Int J Fertil Steril
Pays: Iran
ID NLM: 101487941
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
received:
09
12
2022
pmc-release:
01
01
2024
medline:
2
12
2023
pubmed:
2
12
2023
entrez:
2
12
2023
Statut:
epublish
Résumé
In individuals with coronavirus disease 2019 (COVID-19), male subjects have consistently been linked to poor severity and prognosis. Data on sex hormones in non-critical COVID-19-infected patients are scarce. The aim of this study was to assess the status of total testosterone (TT) and dehydroepiandrosterone sulfate (DHEAS) among noncritical patients with COVID-19 according to sex and their associations with clinical and biochemical features. This cross-sectional observational study was done in the COVID-19 unit of a University hospital during the period of September 2021 to February 2022 among 91 adults (18-65 years) with reverse transcriptase- polymerase chain reaction confirmed noncritical COVID-19 patients. Blood was drawn by venipuncture before receiving steroids between 07:00 to 09:00 a.m. in a fasting state to measure serum TT and DHEAS by chemiluminescent microparticle immunoassay. Diagnosis and classification of COVID-19 were done according to World Health Organization's interim guidance. Age- and sex-specific laboratory reference values were used to classify the TT and DHEAS status of the patients. Only three males (8.1%) had low TT and the rest had normal TT. On the other hand, 15 (27.8%) of the females had high TT with normal levels in the rest. Similarly, 11 (29.7%) males had low DHEAS. Females had low, normal, and high DHEAS in four (7.4%), 48 (88.9%), and two (3.7%) cases respectively. Males with moderate severity of COVID-19 had significantly lower DHEAS (post hoc P=0.038) than the mild group. Both TT (P=0.008) and DHEAS (P=0.023) significantly correlated with neutrophils/lymphocytes ratio and only DHEAS with platelets/lymphocytes ratio (P=0.044) in males. In females, TT significantly correlated with serum sodium (P=0.034). In noncritical COVID-19 patients, substantial gender variations in TT and DHEAS were detected and correlated with severity markers in males.
Sections du résumé
BACKGROUND
BACKGROUND
In individuals with coronavirus disease 2019 (COVID-19), male subjects have consistently been linked to poor severity and prognosis. Data on sex hormones in non-critical COVID-19-infected patients are scarce. The aim of this study was to assess the status of total testosterone (TT) and dehydroepiandrosterone sulfate (DHEAS) among noncritical patients with COVID-19 according to sex and their associations with clinical and biochemical features.
MATERIALS AND METHODS
METHODS
This cross-sectional observational study was done in the COVID-19 unit of a University hospital during the period of September 2021 to February 2022 among 91 adults (18-65 years) with reverse transcriptase- polymerase chain reaction confirmed noncritical COVID-19 patients. Blood was drawn by venipuncture before receiving steroids between 07:00 to 09:00 a.m. in a fasting state to measure serum TT and DHEAS by chemiluminescent microparticle immunoassay. Diagnosis and classification of COVID-19 were done according to World Health Organization's interim guidance. Age- and sex-specific laboratory reference values were used to classify the TT and DHEAS status of the patients.
RESULTS
RESULTS
Only three males (8.1%) had low TT and the rest had normal TT. On the other hand, 15 (27.8%) of the females had high TT with normal levels in the rest. Similarly, 11 (29.7%) males had low DHEAS. Females had low, normal, and high DHEAS in four (7.4%), 48 (88.9%), and two (3.7%) cases respectively. Males with moderate severity of COVID-19 had significantly lower DHEAS (post hoc P=0.038) than the mild group. Both TT (P=0.008) and DHEAS (P=0.023) significantly correlated with neutrophils/lymphocytes ratio and only DHEAS with platelets/lymphocytes ratio (P=0.044) in males. In females, TT significantly correlated with serum sodium (P=0.034).
CONCLUSION
CONCLUSIONS
In noncritical COVID-19 patients, substantial gender variations in TT and DHEAS were detected and correlated with severity markers in males.
Identifiants
pubmed: 38041460
doi: 10.22074/ijfs.2023.1978415.1407
pmc: PMC10692738
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
54-59Références
JAMA Netw Open. 2021 May 3;4(5):e2111398
pubmed: 34032853
Front Immunol. 2022 Jan 27;13:834851
pubmed: 35154158
Med Hypotheses. 2020 Oct;143:110112
pubmed: 32721806
Andrology. 2022 Jan;10(1):34-41
pubmed: 34409772
J Sex Med. 2021 Feb;18(2):256-264
pubmed: 33468445
Andrology. 2022 Jan;10(1):24-33
pubmed: 34288536
Aging Male. 2020 Dec;23(5):1493-1503
pubmed: 32883151
Endocr Relat Cancer. 2021 Feb;28(2):R47-R53
pubmed: 33263566
J Endocrinol Invest. 2022 Mar;45(3):639-648
pubmed: 34731444
Andrology. 2021 Jan;9(1):107-114
pubmed: 33152165
Endocrinology. 2022 Jan 1;163(1):
pubmed: 34543404
Front Endocrinol (Lausanne). 2021 Mar 16;12:607179
pubmed: 33796068
Middle East Fertil Soc J. 2021;26(1):44
pubmed: 34876801
Adv Pharmacol Sci. 2011;2011:817835
pubmed: 21603136
Nat Commun. 2022 Mar 24;13(1):1589
pubmed: 35332140
Front Med (Lausanne). 2020 Dec 08;7:589060
pubmed: 33364247
Int J Infect Dis. 2021 Jul;108:244-251
pubmed: 34023492
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
Endocr Pract. 2021 Feb;27(2):83-89
pubmed: 33554871
Mayo Clin Proc. 2020 Aug;95(8):1710-1714
pubmed: 32753145
J Infect Dis. 2008 Mar 15;197(6):812-6
pubmed: 18269318
Andrology. 2022 Jan;10(1):13-23
pubmed: 34196475
Andrology. 2021 Jan;9(1):88-98
pubmed: 32436355